We are live on ! Find out more
FPC

Falcon Point Capital Portfolio holdings

AUM $11.9M
1-Year Est. Return 55.76%
This Fund
S&P 500
This Quarter Est. Return
-19.42%
1 Year Est. Return
+55.76%
3 Year Est. Return
+118.89%
5 Year Est. Return
+197.9%
10 Year Est. Return
AUM
$167M
AUM Growth
-$298M
Cap. Flow
-$222M
Cap. Flow %
-132.6%
Top 10 Hldgs %
29.81%
Holding
120
New
10
Increased
5
Reduced
70
Closed
18

Sector Composition

Rank Sector Weight
1 Industrials 20.48%
2 Healthcare 18.07%
3 Technology 17.67%
4 Consumer Discretionary 11.43%
5 Consumer Staples 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVAX
76
DELISTED
Dynavax Technologies
DVAX
$283K 0.17%
30,944
+10,921
+55% +$121K
RNG icon
77
RingCentral
RNG
$4.77B
$276K 0.17%
3,351
-172
-5% -$13.5K
SJB icon
78
ProShares Short High Yield
SJB
$51.7M
$276K 0.17%
11,753
PFNX
79
DELISTED
Pfenex Inc.
PFNX
$256K 0.15%
80,205
+2,590
+3% +$11.1K
VRAY
80
DELISTED
ViewRay, Inc.
VRAY
$244K 0.15%
40,277
-22,150
-35% -$166K
GPX
81
DELISTED
GP Strategies Corp.
GPX
$237K 0.14%
18,784
-3,884
-17% -$55.5K
APO.PRA
82
DELISTED
Apollo Global Management, Inc. 6.375% Series A Preferred Shares
APO.PRA
$225K 0.13%
10,000
APEN
83
DELISTED
Apollo Endosurgery, Inc.
APEN
$219K 0.13%
63,609
-13,151
-17% -$64.9K
V icon
84
Visa
V
$697B
$206K 0.12%
1,560
TRTN
85
DELISTED
Triton International Limited
TRTN
$203K 0.12%
6,540
AEM icon
86
Agnico Eagle Mines
AEM
$71.9B
$201K 0.12%
+4,969
New +$183K
ALDX icon
87
Aldeyra Therapeutics
ALDX
$95.3M
$198K 0.12%
23,841
-4,931
-17% -$50.5K
B
88
Barrick Mining
B
$61.5B
$189K 0.11%
+13,934
New +$180K
SPCE icon
89
Virgin Galactic
SPCE
$320M
$154K 0.09%
771
SKIS
90
DELISTED
Peak Resorts, Inc.
SKIS
$140K 0.08%
30,000
CSLT
91
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$128K 0.08%
59,065
-12,211
-17% -$30.3K
GG
92
DELISTED
Goldcorp Inc
GG
$116K 0.07%
+11,855
New +$115K
RCM
93
DELISTED
R1 RCM Inc. Common Stock
RCM
$112K 0.07%
+14,026
New +$121K
ACHC icon
94
Acadia Healthcare
ACHC
$3.01B
-171,702
Closed -$6.04M
ACRS icon
95
Aclaris Therapeutics
ACRS
$744M
-18,965
Closed -$275K
CLSD
96
DELISTED
Clearside Biomedical
CLSD
-2,081
Closed -$192K
DECK icon
97
Deckers Outdoor
DECK
$14.2B
-359,946
Closed -$7.11M
GHM icon
98
Graham Corp
GHM
$1.17B
-8,525
Closed -$240K
MA icon
99
Mastercard
MA
$497B
-1,148
Closed -$256K
NERV icon
100
Minerva Neurosciences
NERV
$199M
-3,492
Closed -$351K

Similar funds

Falcon Point Capital's Q4 2018 Portfolio in Review

As of Q4 2018, Falcon Point Capital held 120 positions worth $167M, down 64% from $466M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Falcon Point Capital withdrew a net $222M in Q4 2018, closing 18 positions and reducing 70 holdings. Its most notable exit was Deckers Outdoor, an estimated $7.11M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Falcon Point Capital opened a new position in Myriad Genetics worth $2.09M.

  • Falcon Point Capital's largest Q4 2018 buy was Myriad Genetics: 71,927 shares worth $2.09M.
  • Falcon Point Capital added most to SeaSpine Holdings Corporation Common Stock in Q4 2018, an estimated $2.54M increase.
  • Falcon Point Capital's biggest Q4 2018 reduction was Mandiant, Inc. Common Stock, cutting an estimated $10.6M.
  • Falcon Point Capital fully exited Deckers Outdoor in Q4 2018, selling an estimated $7.11M.
  • Falcon Point Capital's ten largest holdings make up 30% of its $167M portfolio in Q4 2018.
  • Falcon Point Capital opened 10 new positions and closed 18 in Q4 2018.
  • Falcon Point Capital's portfolio value fell 64% quarter-over-quarter to $167M.

Based on Falcon Point Capital's 13F filing for Q4 2018, filed 31 Jan 2019.